[1]
D. Cohen, MA/LS, “Abuse-deterrent formulations approval reform: Will clinical correctness or real-world results be used to address the nation’s opioid crisis: ‘Noninterference’ as a new approval standard”, J of Opioid Management, vol. 13, no. 6, pp. 357–362, Dec. 2017.